Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Clinical Endpoints
100%
Primary Sclerosing Cholangitis
100%
Total IgE
100%
Cholangiocarcinoma
70%
Free Survival
30%
Liver Transplantation
20%
Risk Score
20%
MELD Score
20%
IgG Subclasses
20%
Multivariate Analysis
10%
Clinical Characteristics
10%
Significant Predictors
10%
Serum IgE
10%
Hepatobiliary Disease
10%
Composite Endpoint
10%
Group-based
10%
No Significant Difference
10%
Median Survival Time
10%
Major Adverse Events
10%
Proportional Hazards Model
10%
Sample Median
10%
Sample Age
10%
Japanese Population
10%
Western US
10%
Medicine and Dentistry
Primary Sclerosing Cholangitis
100%
Clinical Endpoint
100%
Immunoglobulin E
100%
Cholangiocarcinoma
70%
Liver Transplantation
20%
Adverse Event
10%
Hepatobiliary Disease
10%
Proportional Hazards Model
10%
Median Survival Time
10%
Multivariate Analysis
10%
Pharmacology, Toxicology and Pharmaceutical Science
Primary Sclerosing Cholangitis
100%
Immunoglobulin E
100%
Bile Duct Carcinoma
70%
Adverse Event
10%
Median Survival Time
10%
Hepatobiliary Disease
10%
Immunology and Microbiology
Primary Sclerosing Cholangitis
100%
Immunoglobulin E
100%
Liver Transplantation
20%
Median Survival Time
10%